Table 2.
Changes in the number of isolates of bacteria and fungi detected in blood culture.
| Emergency department | Fiscal year 2019 |
Fiscal year 2020 |
p-valuea | |
|---|---|---|---|---|
| n = 86 | n = 95 | |||
| GPC | 58 (67.4%) | 61 (64.2) | 0.75 | |
| Staphylococcus aureus | 15 (17.4%) | 7 (7.4%) | 0.04 | |
| MSSA | 10 (11.6%) | 3 (3.2%) | 0.04 | |
| MRSA | 5 (5.8%) | 4 (4.2%) | 0.74 | |
| CNS | 22 (25.6%) | 32 (33.7%) | 0.26 | |
| MRCNS | 16 (18.6%) | 26 (27.4%) | 0.22 | |
| GPR | 19 (22.1%) | 20 (21.1%) | >0.99 | |
| GNC | 0 (0%) | 0 (0%) | >0.99 | |
| GNR | 23 (26.7%) | 19 (20.0%) | 0.3 | |
| ESBL (+) | 3 (3.5%) | 2 (2.1%) | 0.67 | |
| AmpC (+) | 2 (2.3%) | 2 (2.1%) | >0.99 | |
| CRE | 0 (0%) | 1 (1.1%) | >0.99 | |
| Pseudomonas spp. | 2 (2.3%) | 2 (2.1%) | >0.99 | |
| Fungi |
1 (1.2%) |
2 (2.1%) |
>0.99 |
|
| Clinical departments other than the emergency department |
n = 343 |
n = 287 |
p-valuea |
|
| GPC | 197 (57.4%) | 149 (51.9%) | 0.17 | |
| Staphylococcus aureus | 48 (14.0%) | 23 (8.0%) | 0.02 | |
| MSSA | 35 (10.2%) | 12 (4.2%) | <0.01 | |
| MRSA | 13 (3.8%) | 11 (3.8%) | >0.99 | |
| CNS | 31 (9.0%) | 27 (9.4%) | 0.89 | |
| MRCNS | 68 (19.8%) | 55 (19.2%) | 0.84 | |
| GPR | 45 (13.1%) | 30 (10.5%) | 0.33 | |
| GNC | 2 (0.6%) | 2 (0.7%) | >0.99 | |
| GNR | 128 (37.3%) | 123 (42.9%) | 0.17 | |
| ESBL (+) | 16 (4.7%) | 10 (3.5%) | 0.55 | |
| AmpC (+) | 17 (5.0%) | 9 (3.1%) | 0.32 | |
| CRE | 3 (0.9%) | 3 (1.0%) | >0.99 | |
| Pseudomonas spp. | 9 (2.6%) | 21 (7.3%) | <0.01 | |
| Fungi | 2 (0.6%) | 6 (2.1%) | 0.15 | |
CNS, coagulase-negative staphylococci; CRE, carbapenem-resistant Enterobacteriaceae; ESBL, extended spectrum beta-lactamase; GNC, gram negative cocci; GNR, gram negative rod; GPC, gram positive cocci; GPR, gram positive rod; MRCNS, methicillin-resistant coagulase-negative staphylococci; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus..
a
Fisher's exact test.